Stockholm - Free Realtime Quote SEK

Initiator Pharma A/S (INIT.ST)

Compare
7.00
-0.10
(-1.41%)
As of 3:34:33 PM GMT+1. Market Open.
Currency in DKK All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Gross Profit
-13,755.00
-23,413.00
-38,425.00
-21,626.00
-9,299.00
Operating Expense
--
--
3,315.00
1,446.00
1,232.00
Operating Income
-18,039.00
-27,030.00
-41,740.00
-23,072.00
-10,531.00
Net Non Operating Interest Income Expense
--
--
-2,392.00
-1,172.00
291.00
Pretax Income
-16,927.00
-27,707.00
-44,132.00
-24,244.00
-10,240.00
Tax Provision
-4,834.00
-4,834.00
-5,677.00
-3,180.00
-1,543.00
Net Income Common Stockholders
-12,093.00
-22,873.00
-38,455.00
-21,064.00
-8,697.00
Diluted NI Available to Com Stockholders
-12,093.00
-22,873.00
-38,455.00
-21,064.00
-8,697.00
Basic EPS
-0.20
-0.44
-0.80
-0.60
-0.32
Diluted EPS
-0.20
-0.44
-0.80
-0.60
-0.32
Basic Average Shares
54,740.02
52,419.18
48,325.35
35,088.33
27,375.42
Diluted Average Shares
57,497.31
57,269.80
53,225.96
39,685.39
28,990.00
Total Operating Income as Reported
-18,039.00
-27,030.00
-41,740.00
-23,072.00
-10,531.00
Total Expenses
--
--
3,315.00
1,446.00
1,232.00
Net Income from Continuing & Discontinued Operation
-12,093.00
-22,873.00
-38,455.00
-21,064.00
-8,697.00
Normalized Income
-12,093.00
-22,873.00
-38,455.00
-21,064.00
-8,697.00
Interest Income
--
--
--
--
291.00
Interest Expense
--
677.00
2,392.00
1,172.00
--
Net Interest Income
--
--
-2,392.00
-1,172.00
291.00
EBIT
-18,039.00
-27,030.00
-41,740.00
-23,072.00
-10,531.00
EBITDA
-18,039.00
-27,030.00
-41,740.00
-23,061.00
-10,505.00
Reconciled Depreciation
--
--
--
11.00
26.00
Net Income from Continuing Operation Net Minority Interest
-12,093.00
-22,873.00
-38,455.00
-21,064.00
-8,697.00
Normalized EBITDA
-18,039.00
-27,030.00
-41,740.00
-23,061.00
-10,505.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
12/31/2020 - 3/16/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ZICC.ST Ziccum AB (publ)
0.2500
0.00%
 
KTTAW Pasithea Therapeutics Corp.
0.0251
-32.16%
 
NLSPW NLS Pharmaceutics AG
0.0170
+30.57%
 
DRMAW Dermata Therapeutics, Inc.
0.0297
0.00%
 
ACE.ST Ascelia Pharma AB (publ)
2.9150
+1.92%
 
SANION.ST Saniona AB (publ)
7.76
-1.27%
 
GMAB.CO Genmab A/S
1,423.50
+0.96%
 
MNMD Mind Medicine (MindMed) Inc.
7.16
+0.43%
 
CRSP CRISPR Therapeutics AG
42.29
+0.59%
 
VKTX Viking Therapeutics, Inc.
34.29
+1.78%